More from Investing
We had the Fed's rate decision, jobs numbers, and mega-cap tech earnings land. But here's what was the wildest action.
These names have joined the ranks of the world's most elite dividend growth companies as Dividend Aristocrats and/or Dividend Kings.
Here's the picture we see from this payment company.
Let's review the charts of XBI, the SPDR S&P Biotech ETF.